management picture

Claudia Lebedinsky, MD

Senior Vice President, Head of Clinical Development

Dr. Claudia Lebedinsky serves as Senior Vice President, Head of Clinical Development of AVEO Oncology, an LG Chem company, bringing more than 20 years of experience in oncology and clinical development to the organization.  

Dr. Lebedinsky most recently served as Vice President, Head of Clinical Development at Sumitomo Pharma Oncology (Sumitomo), where she led the clinical development of novel small molecules and peptides vaccines. Prior to her time at Sumitomo, Dr. Lebedinsky held a variety of clinical development roles for early and late phase drug development at multiple companies, including PharmaMar, Sanofi Oncology, Novartis AG and Baxalta (a subsidiary of Takeda Pharmaceutical Company, a Dyax Corporation). During this time, Dr. Lebedinsky led the development of several marketed oncology drugs, including YONDELIS®, INREBIC®, and ASPARLAS®. Dr. Lebedinsky conducted her residence in medical oncology at Instituto de Oncologia Roffo, Argentina. She is a board-certified medical oncologist by Argentina Ministry of Health and Spain Ministry of Health.